Navigation Links
ICAP Ocean Tomo Offers IP Portfolio of Near-Infrared Spectroscopy Technology
Date:7/6/2010

CHICAGO, July 6 /PRNewswire/ -- ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L), has been engaged to sell a patent portfolio of near-infrared spectroscopy technology owned by NIResults Inc. The portfolio includes over 90 issued US and foreign patents and patent applications.  The assets have been cited by over 20 companies including Abbott Laboratories, Baxter International, Bayer Healthcare, Beckman Coulter Inc., Xerox, and Hewlett Packard.

(Logo: http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100614/CG20517LOGO)

The patents of this portfolio cover the use of near-infrared spectroscopy in clinical chemistry analysis systems, pulse oximeters and CO-oximeters, non-invasive glucose monitors, and hemoglobin monitors. The patents describe a method for the monitoring of key blood analytes without the need for costly, environmentally challenging, chemical reagents. The assets also include in-vitro, which is applied to a droplet of blood from a sample, and in-vivo (non-invasive) technology, which does not require a blood sample. Using near-infrared spectroscopy technology to count analytes in the blood eliminates the disadvantages associated with conventional methods such as the risk of patient infection and discomfort from invasive sampling methods and erroneous test results due to time delays between when the blood is drawn and analyzed.

"This portfolio will provide the purchaser with the coverage necessary to develop next generation monitoring devices," said Dean Becker, ICAP Ocean Tomo CEO. This portfolio should be of interest to any entity involved in diabetes management or blood monitoring markets, or developing products for analyte measurement.

To learn more about the patents available for sale in this portfolio or how to sell or buy intellectual property please contact ICAP Ocean Tomo at 1-866-779-8363 or at patent.brokerage@us.icap.com.

About ICAP Ocean Tomo LLC

ICAP Ocean Tomo is the intellectual property brokerage division of ICAP.

About ICAP

ICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP is also the source of global market information and research for professionals in the international financial markets. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to www.icap.com.


'/>"/>
SOURCE ICAP Ocean Tomo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing
2. Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
3. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
4. HealthWarehouse.com Now Offers Over 1,000 Medications Under $25 Bringing Increased Affordability to Consumers
5. BSGI Offers Improved Cancer Detection for Negative or Indeterminate Mammograms
6. In the Face of Pain® Offers Social Media 101 for Pain Management Advocates
7. Medicalequipmentpro.com Offers Fathers Day Discounts to Ensure this Fathers Day is a Healthy One
8. Prolifiq Offers Best Practices Solution for Selling Medical Devices in Tough Regulatory Environment
9. Gold Standard/Elsevier Offers Timely, Transparent, Reliable Drug Pricing Data, Including Average Wholesale Price (AWP)
10. Blog Contest Offers Graduate Students the Chance to Win a Trip to Zambia
11. BSGI Offers Clear View of Breast Tumor Response to Neoadjuvant Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016  PipelineRx, a leading medication management technology ... demonstrations of its SaaS-based telepharmacy platform, PowerGridRx™ ... 2016 Midyear Clinical Meeting and Exhibition, December 5-7 ... nearly 300 hospital clients nationally, the Company is ... to dramatically improve pharmacy operations, enhance patient safety, ...
(Date:12/2/2016)... , Dec. 2, 2016  Eli Lilly and ... financial guidance for 2017 and provide updated financial guidance ... also conduct a conference call on that day with ... company,s financial guidance. The conference call will ... general public can access a live webcast of the ...
(Date:12/2/2016)... MARLBOROUGH, Mass. , Dec. 2, 2016 ... announced a definitive agreement to acquire certain manufacturing assets ... NVCN ) (TSX: NVC) advanced biological tissue business, as ... a total of $75 million in cash. The Neovasc ... heart valves, including the Boston Scientific Lotus™ Valve System. ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of ... of an injury, patients must find the one that works for them. When an ... created a machine that worked and decided to share it with others. , He ...
(Date:12/2/2016)... ... ... Mediaplanet is proud to announce the launch of its ... therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage their ... the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This is ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... Sourced from ... has some unique properties including its unmatched natural purity of just 6 ppm TDS ... and crisp. , Nothing Water has been available in several ShopRite and FoodTown stores ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health Solutions, ... raised $6.0 million in an initial round of funding. The round was led ... their caregivers can receive far better care through the application of the best ...
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 creative ... National Family Partnership and the Drug Enforcement Administration as part of the National Red ... 10 winning schools who decorated their campuses with this year’s Red Ribbon Week theme: ...
Breaking Medicine News(10 mins):